Veracyte (VCYT) Total Liabilities (2012 - 2026)

Veracyte has reported Total Liabilities for 15 years, with the latest figure at $98.0 million in Q2 2026.

• Total Liabilities for Q2 2026 came in at $98.0 million, down 20.39% year-over-year; the trailing twelve-month figure through Jun 2026 was $98.0 million (down 20.39% YoY), and the FY2025 annual result was $96.4 million, down 22.27% from the prior year.
• Total Liabilities rose to $98.0 million in Q2 2026, from $92.0 million in the prior quarter.
• Over five years, Total Liabilities peaked at $124.1 million in Q4 2024 and troughed at $70.8 million in Q4 2023.
• A 5-year average of $92.8 million and a median of $90.2 million in 2022 frame the typical range for Total Liabilities.
• The widest annual swing landed in 2024, when Total Liabilities surged 75.23%; it then fell 23.64% in 2026.
• A 5-year view of Total Liabilities shows it stood at $81.2 million in 2022, then decreased by 12.83% to $70.8 million in 2023, then jumped by 75.23% to $124.1 million in 2024, then decreased by 22.27% to $96.4 million in 2025, then rose by 1.58% to $98.0 million in 2026.
• Per Business Quant data, the three most recent Total Liabilities figures were $98.0 million in Q2 2026, $92.0 million in Q1 2026, and $96.4 million in Q4 2025.